Objective
This project studies risks, mechanisms and susceptibility in the aetiology of bladder, skin and kidney cancers in relation to arsenic in drinking water. For 1200 cases and 600 controls, estimates of cumulative dose will be constructed and cancer risks will be estimated in relation to arsenic intake, adjusting for potential confounding by diet, tobacco and occupation. The impact on risk of individual differences in arsenic metabolism, DNA repair and diet will be assessed. For sub groups of the population more detailed analyses of inter-individual differences in speciation, the effect of other nutrients and minerals, and specific polymorphisms will inform models of metabolism. Risk management will be explored for those with the highest continuing exposure. The project will improve quantitative risk assessments, understanding of mechanisms of arsenic toxicity and communication among European researchers in this field.
Fields of science
- engineering and technologyenvironmental engineeringwater treatment processesdrinking water treatment processes
- medical and health scienceshealth sciencespublic healthepidemiology
- medical and health scienceshealth sciencesnutrition
- medical and health sciencesclinical medicineoncology
- social sciencessociologygovernancecrisis management
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
WC1E 7HT LONDON
United Kingdom